TABLE 4.
Patients’ practice in the pharmacovigilance system.
| Characteristic | Diagnostic response | Interventional response |
|---|---|---|
| n (%) | n (%) | |
| Experience of adverse drug reactions during the lifetime | ||
| a. Yes | 194 (45.9%) | 194 (45.9%) |
| b. No | 229 (54.1%) | 229 (54.1%) |
| Did you report adverse drug reactions to anyone? | ||
| a. Yes | 127 (30.02%) | 127 (30.02%) |
| b. No | 296 (69.98%) | 296 (69.98%) |
| I will be reporting adverse drug reactions in future | ||
| a. Yes | 242 (57.2%) | 420 (99.3%) |
| b. No | 181 (42.8%) | 3 (0.7%) |
| Prescribing and dispensing time should be improved to prevent adverse drug reactions | ||
| a. Yes | 252 (59.5%) | 332 (78.5%) |
| b. No | 171 (40.5%) | 91 (21.5%) |
| Have you noticed/remembered any adverse drug reactions reported in the media? | ||
| a. Yes | 240 (56.7%) | 257 (60.8%) |
| b. No | 183 (43.3%) | 166 (39.2%) |
| Is there need of pharmacovigilance centers in hospitals? | ||
| a. Yes | 240 (56.7%) | 414 (97.9%) |
| b. No | 183 (43.3%) | 9 (2.1%) |
| Reporting of adverse reactions by drugs is beneficial for the populace as it reduces re-occurrence | ||
| a. Yes* | 260 (61.5%) | 374 (88.4%) |
| b. No | 163 (38.5%) | 49 (11.6%) |
| Adverse drug reactions are a serious concern for healthcare stakeholders in Pakistan | ||
| a. Yes* | 226 (53.4%) | 418 (98.8%) |
| b. No | 197 (46.6%) | 5 (1.2%) |
*Correct response.